"Calcium Channel Blockers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
Descriptor ID |
D002121
|
MeSH Number(s) |
D27.505.519.562.249 D27.505.954.411.192
|
Concept/Terms |
Calcium Channel Blockers- Calcium Channel Blockers
- Blockers, Calcium Channel
- Channel Blockers, Calcium
- Calcium Channel Antagonists
- Antagonists, Calcium Channel
- Calcium Channel Blocking Drugs
Calcium Antagonists, Exogenous- Calcium Antagonists, Exogenous
- Antagonists, Exogenous Calcium
- Exogenous Calcium Inhibitors
- Exogenous Calcium Antagonists
- Exogenous Calcium Blockaders
- Calcium Blockaders, Exogenous
- Calcium Inhibitors, Exogenous
|
Below are MeSH descriptors whose meaning is more general than "Calcium Channel Blockers".
Below are MeSH descriptors whose meaning is more specific than "Calcium Channel Blockers".
This graph shows the total number of publications written about "Calcium Channel Blockers" by people in this website by year, and whether "Calcium Channel Blockers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 0 | 1 | 1 |
1996 | 1 | 1 | 2 |
1997 | 0 | 2 | 2 |
1998 | 1 | 4 | 5 |
1999 | 5 | 1 | 6 |
2000 | 2 | 2 | 4 |
2001 | 0 | 2 | 2 |
2002 | 0 | 4 | 4 |
2003 | 1 | 1 | 2 |
2004 | 5 | 2 | 7 |
2005 | 1 | 2 | 3 |
2006 | 1 | 4 | 5 |
2007 | 3 | 1 | 4 |
2008 | 3 | 1 | 4 |
2009 | 2 | 1 | 3 |
2010 | 0 | 8 | 8 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 1 | 2 | 3 |
2015 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 3 | 4 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Calcium Channel Blockers" by people in Profiles.
-
Blood Pressure Control Among Non-Hispanic Black Adults Is Lower Than Non-Hispanic White Adults Despite Similar Treatment With Antihypertensive Medication: NHANES 2013-2018. Am J Hypertens. 2022 Jun 16; 35(6):514-525.
-
Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach. J Hypertens. 2022 03 01; 40(3):462-469.
-
Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells. Front Immunol. 2021; 12:803335.
-
Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016. Am J Cardiol. 2021 Aug 01; 152:168.
-
Emergency Department Management of Recent-Onset Atrial Fibrillation. Adv Emerg Nurs J. 2020 Jul/Sep; 42(3):176-185.
-
Weight-based versus non-weight-based diltiazem dosing in the setting of atrial fibrillation with rapid ventricular response. Am J Emerg Med. 2020 11; 38(11):2271-2276.
-
2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Circulation. 2019 08 20; 140(8):e333-e381.
-
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018 06; 71(6):1064-1074.
-
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas. J Clin Oncol. 2018 06 10; 36(17):1702-1709.
-
Distal Esophageal Spasm: A Review. Am J Med. 2018 09; 131(9):1034-1040.